Enhanced selective lymphatic delivery of cyclosporin a by solubilizers and intensified immunosuppressive activity against mice skin allograft.

Enhanced percutaneous absorption of a novel topical cyclosporin A formulation and assessment of its immunosuppressive activity.

New cyclosporin A analogue: synthesis and immunosuppressive activity.

Treatment of acute myeloid leukaemia in a renal allograft recipient: implications of cyclosporin immunosuppressive treatment.

Enhanced skin delivery of vismodegib by microneedle treatment.

Assessment of the in vivo immunosuppressive activity of the major cyclosporine metabolite by leukemia allograft rejection.

Enhanced effectiveness of tocotrienol-based nano-emulsified system for topical delivery against skin carcinomas.

Mediation of skin allograft rejection in scid mice by CD4+ and CD8+ T cells.

Cardiac-allograft survival in primates treated with cyclosporin A.

Tracheal allograft after withdrawal of immunosuppressive therapy.

In vitro activity of immunosuppressive drugs against Plasmodium falciparum.

Formulation and evaluation of Cyclosporin A emulgel for ocular delivery.

The synergistic immunosuppressive potential of cyclosporin metabolite combinations.

Potentiation of vascular smooth muscle cell activity by cyclosporin A.

Further evidence that cyclosporin A protects mitochondria from calcium overload by inhibiting a matrix peptidyl-prolyl cis-trans isomerase. Implications for the immunosuppressive and toxic effects of cyclosporin.

Microneedle enhanced delivery of cosmeceutically relevant peptides in human skin.

Surface-modified solid lipid nanoparticles for oral delivery of docetaxel: enhanced intestinal absorption and lymphatic uptake.

Inhibition of Lymphatic Drainage With a Self-Designed Surgical Approach Prolongs the Vascularized Skin Allograft Survival in Rats.

Inhibition of human immunodeficiency virus and growth of infected T cells by the immunosuppressive drugs cyclosporin A and FK 506.

Incidentally detected lymphatic filariasis in a renal allograft recipient.

Synthesis and antifilarial activity of chalcone-thiazole derivatives against a human lymphatic filarial parasite, Brugia malayi.

Selective uptake of single-walled carbon nanotubes by circulating monocytes for enhanced tumour delivery.

Is cyclophilin involved in the immunosuppressive and nephrotoxic mechanism of action of cyclosporin A?

Lymphocyte-selective antiproliferative and immunosuppressive effects of mycophenolic acid in mice.

Effect of FK506 and cyclosporine on primary and secondary skin allograft survival in mice.

Suggest Documents

Enhanced percutaneous absorption of a novel topical cyclosporin A formulation and assessment of its immunosuppressive activity.

New cyclosporin A analogue: synthesis and immunosuppressive activity.

Treatment of acute myeloid leukaemia in a renal allograft recipient: implications of cyclosporin immunosuppressive treatment.

Enhanced skin delivery of vismodegib by microneedle treatment.

Assessment of the in vivo immunosuppressive activity of the major cyclosporine metabolite by leukemia allograft rejection.

Enhanced effectiveness of tocotrienol-based nano-emulsified system for topical delivery against skin carcinomas.

Mediation of skin allograft rejection in scid mice by CD4+ and CD8+ T cells.

Cardiac-allograft survival in primates treated with cyclosporin A.

Tracheal allograft after withdrawal of immunosuppressive therapy.

In vitro activity of immunosuppressive drugs against Plasmodium falciparum.

Formulation and evaluation of Cyclosporin A emulgel for ocular delivery.

The synergistic immunosuppressive potential of cyclosporin metabolite combinations.

Potentiation of vascular smooth muscle cell activity by cyclosporin A.

Further evidence that cyclosporin A protects mitochondria from calcium overload by inhibiting a matrix peptidyl-prolyl cis-trans isomerase. Implications for the immunosuppressive and toxic effects of cyclosporin.

Microneedle enhanced delivery of cosmeceutically relevant peptides in human skin.

Surface-modified solid lipid nanoparticles for oral delivery of docetaxel: enhanced intestinal absorption and lymphatic uptake.

Inhibition of Lymphatic Drainage With a Self-Designed Surgical Approach Prolongs the Vascularized Skin Allograft Survival in Rats.

Inhibition of human immunodeficiency virus and growth of infected T cells by the immunosuppressive drugs cyclosporin A and FK 506.

Incidentally detected lymphatic filariasis in a renal allograft recipient.

Synthesis and antifilarial activity of chalcone-thiazole derivatives against a human lymphatic filarial parasite, Brugia malayi.

Selective uptake of single-walled carbon nanotubes by circulating monocytes for enhanced tumour delivery.

Is cyclophilin involved in the immunosuppressive and nephrotoxic mechanism of action of cyclosporin A?

Lymphocyte-selective antiproliferative and immunosuppressive effects of mycophenolic acid in mice.

Effect of FK506 and cyclosporine on primary and secondary skin allograft survival in mice.

Enhanced selective lymphatic delivery of cyclosporin a by solubilizers and intensified immunosuppressive activity against mice skin allograft.

Recommend Documents

Follow Us